(-)-2β-(1,2,4-Oxadiazol-5-methyl)-3β-phenyltropane

(-)-2β-(1,2,4-Oxadiazol-5-methyl)-3β-phenyltropane
Legal status
Legal status
  • NZ: Temporary Class Drug
Identifiers
CAS Number 146659-37-2
HCl: 147059-95-8
PubChem (CID) 71095000
Chemical and physical data
Formula C17H21N3O
Molar mass 283.367 g/mol
3D model (Jmol) Interactive image

RTI(-4229)-126 ((–)-2β-(1,2,4-oxadiazol-5-methyl)-3β-phenyltropane) is a phenyltropane derivative which acts as a potent monoamine reuptake inhibitor and stimulant drug. It is around 5 times more potent a stimulant than cocaine, but is relatively unselective. It binds to all three monoamine transporters, although still with some selectivity for the dopamine transporter.[1] RTI-126 has a fast onset of effects and short duration of action, and its pharmacological profile in animals is among the closest to cocaine itself out of all the drugs in the RTI series. Its main application in scientific research has been in studies investigating the influence of pharmacokinetics on the abuse potential of stimulant drugs, with its rapid entry into the brain thought to be a key factor in producing its high propensity for development of dependence in animals.[2][3]

The structurally related compound (–)-2β-(3-methyl-5-isoxazolyl)nortropane is a potent and selective agonist for nicotinic acetylcholine receptors, with twice the potency of nicotine.[4]

(–)-2β-(3-methyl-5-isoxazolyl)nortropane

See also

References

  1. ↑ Carroll, FI; Gray, JL; Abraham, P; Kuzemko, MA; Lewin, AH; Boja, JW; Kuhar, MJ (1993). "3-Aryl-2-(3′-substituted-1′,2′,4′-oxadiazol-5′-yl)tropane analogues of cocaine: affinities at the cocaine binding site at the dopamine, serotonin, and norepinephrine transporters". Journal of Medicinal Chemistry. 36 (20): 2886–90. doi:10.1021/jm00072a007. PMID 8411004.
  2. ↑ Kimmel, HL; Carroll, FI; Kuhar, MJ (2001). "Locomotor stimulant effects of novel phenyltropanes in the mouse". Drug and Alcohol Dependence. 65 (1): 25–36. doi:10.1016/S0376-8716(01)00144-2. PMID 11714587.
  3. ↑ Kimmel, HL; O'Connor, JA; Carroll, FI; Howell, LL (2007). "Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys". Pharmacology, Biochemistry, and Behavior. 86 (1): 45–54. doi:10.1016/j.pbb.2006.12.006. PMC 1850383Freely accessible. PMID 17258302.
  4. ↑ Cheng J, Izenwasser S, Zhang C, Zhang S, Wade D, Trudell ML. Synthesis and nicotinic acetylcholine receptor binding affinities of 2- and 3-isoxazolyl-8-azabicyclo[3.2.1]octanes. Bioorganic and Medicinal Chemistry Letters. April 2004; 14(7):1775-1778. doi:10.1016/j.bmcl.2004.01.025 PMID 15026069


This article is issued from Wikipedia - version of the 11/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.